Title : Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial.

Pub. Date : 2017 Jul 20

PMID : 28724799






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The aim of this study was to assess the effects of galantamine, a centrally acting acetylcholinesterase inhibitor with antiinflammatory properties, on markers of inflammation implicated in insulin resistance and cardiovascular risk, and other metabolic and cardiovascular indices in subjects with MetS. Galantamine acetylcholinesterase (Cartwright blood group) Homo sapiens